22.33

0.84% 0.1986

Elanco Animal Health Inc (ELAN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$22.13

Offen:

$22.31

24-Stunden-Volumen:

51,155

Relative Volume:

0.01

Marktkapitalisierung:

$11.16B

Einnahmen:

$4.89B

Nettoeinkommen (Verlust:

$-242.00M

KGV:

-45.66

EPS:

-0.489

Netto-Cashflow:

$315.00M

1W Leistung:

-7.79%

1M Leistung:

-11.24%

6M Leistung:

-11.20%

1J Leistung:

+25.29%

1-Tages-Spanne:

$22.31

$22.39

1-Wochen-Bereich:

$21.32

$24.41

52-Wochen-Spanne:

$17.11

$27.98

Elanco Animal Health Inc Stock (ELAN) Company Profile

Firmenname

Elanco Animal Health Inc

Sektor

Healthcare (1082)

Branche

Drug Manufacturers - Specialty & Generic (88)

Telefon

877-352-6261

Adresse

450 ELANCO CIRCLE, INDIANAPOLIS

Mitarbeiter

9,900

Twitter

@Elanco

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

ELAN's Discussions on Twitter

Compare ELAN vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ELAN Elanco Animal Health Inc	22.33	11.06B	4.89B	-242.00M	315.00M	-0.489
TAK Takeda Pharmaceutical Co Adr	17.42	55.60B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.815	43.16B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	36.87	42.81B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	74.19	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	510.43	21.95B	3.17B	1.29B	1.01B	27.09

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Eingeleitet	Citigroup	Buy
2026-01-22	Hochstufung	Piper Sandler	Neutral → Overweight
2025-12-09	Eingeleitet	Barclays	Overweight
2025-11-21	Eingeleitet	KeyBanc Capital Markets	Overweight
2025-11-19	Hochstufung	Argus	Hold → Buy
2025-10-07	Hochstufung	JP Morgan	Neutral → Overweight
2025-07-17	Hochstufung	Leerink Partners	Market Perform → Outperform
2025-06-26	Hochstufung	William Blair	Mkt Perform → Outperform
2024-12-09	Eingeleitet	UBS	Buy
2024-12-02	Eingeleitet	Leerink Partners	Market Perform
2024-09-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-01-05	Hochstufung	Stifel	Hold → Buy
2023-12-19	Eingeleitet	Jefferies	Buy
2023-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Eingeleitet	Exane BNP Paribas	Outperform
2023-04-20	Hochstufung	Barclays	Equal Weight → Overweight
2022-08-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Herabstufung	JP Morgan	Overweight → Neutral
2022-07-21	Herabstufung	Goldman	Buy → Sell
2022-07-12	Eingeleitet	Piper Sandler	Neutral
2021-11-18	Eingeleitet	Morgan Stanley	Overweight
2021-10-28	Herabstufung	Stifel	Buy → Hold
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-06-15	Hochstufung	Cleveland Research	Underperform → Neutral
2021-05-11	Hochstufung	Barclays	Underweight → Equal Weight
2021-05-11	Hochstufung	Gabelli & Co	Hold → Buy
2021-04-15	Eingeleitet	Stifel	Buy
2021-03-22	Herabstufung	Gabelli & Co	Buy → Hold
2021-02-26	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-09	Herabstufung	Argus	Buy → Hold
2020-11-09	Herabstufung	Barclays	Overweight → Underweight
2020-08-20	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Fortgesetzt	Credit Suisse	Neutral
2020-08-04	Fortgesetzt	Goldman	Buy
2020-07-27	Herabstufung	Cleveland Research	Neutral → Underperform
2020-04-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Eingeleitet	Raymond James	Mkt Perform
2019-12-19	Hochstufung	BofA/Merrill	Neutral → Buy
2019-11-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Eingeleitet	Barclays	Overweight
2019-08-26	Herabstufung	BofA/Merrill	Buy → Neutral
2019-08-15	Hochstufung	UBS	Sell → Neutral
2019-05-23	Eingeleitet	Guggenheim	Neutral
2019-03-18	Hochstufung	BofA/Merrill	Neutral → Buy
2019-03-13	Fortgesetzt	Morgan Stanley	Equal-Weight
2019-02-12	Eingeleitet	William Blair	Mkt Perform
2019-01-23	Eingeleitet	UBS	Sell
2019-01-15	Eingeleitet	Argus	Buy
2018-10-15	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten

Aug 12, 2026

Elanco Animal Health expands US screwworm response - foxbusiness.com

Aug 12, 2026

Elanco (ELAN): Innovation Is Turning A Leveraged Portfolio Into A Share-Taking Platform - Seeking Alpha

Aug 12, 2026

Aug 11, 2026

Elanco Animal Health Incorporated (ELAN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 11, 2026

Elanco Animal Health (ELAN) Insider Buying: EVP and CFO Robert V - GuruFocus

Aug 11, 2026

Elanco's CLiK(TM) Extra (Dicyclanil Topical Suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Speci - ACCESS Newswire

Aug 11, 2026

Aug 10, 2026

Insider Buying: Elanco Animal Health (NYSE:ELAN) CFO Buys $96,936.00 in Stock - MarketBeat

Aug 10, 2026

Insider Buying: Elanco Animal Health (NYSE:ELAN) Director Buys 10,000 Shares of Stock - MarketBeat

Aug 10, 2026

ELAN Stock Jumps As Earnings Beat Fuels Bullish Guidance - StocksToTrade

Aug 10, 2026

Elanco Animal Health (NYSE: ELAN) EVP granted new deferred stock units - Stock Titan

Aug 10, 2026

Elanco (ELAN) CFO boosts stake with 4,200-share buy and new Deferred Stock Units - Stock Titan

Aug 10, 2026

Elanco (ELAN) CEO Jeffrey Simmons receives new deferred stock unit grant - Stock Titan

Aug 10, 2026

Elanco Animal Health (NYSE: ELAN) director buys 10,000 shares at $23.69 - Stock Titan

Aug 10, 2026

Bank of America Corp DE Has $80.36 Million Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat

Aug 10, 2026

Aug 09, 2026

Does Elanco (ELAN) Have a Durable Edge in Animal Health After Its Screwworm EUA Win? - Yahoo! Finance Canada

Aug 09, 2026

Elanco Animal Health (ELAN) Following FDA Emergency Use Authorization Has Valuation Back In Focus - Yahoo Finance

Aug 09, 2026

Aug 08, 2026

INVESTOR ALERT AND NOTICE: Kaskela Law Firm Announces Investigati - The National Law Review

Aug 08, 2026

Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Aug 08, 2026